- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
J.B Chemicals & Pharma announces DJSI score of 77

Mumbai: J.B. Chemicals & Pharmaceuticals Limited has announced that latest ESG score has been announced by Dow Jones Sustainability Index (DJSI), one of the world’s premier indexes in terms of sustainability.
J. B. Chemicals & Pharmaceuticals Limited’s DJSI score is 77, which will rank presently among the leading pharmaceutical companies in India and also rank among the leaders in Pharma Globally (Sector: DRG Pharmaceuticals, DJSI, S&P Global).
"This achievement underscores the Company’s steadfast commitment to sustainability, corporate responsibility, and environmental, social, and governance (ESG) excellence," JB Chemicals stated.
The DJSI ranking is a premier globally recognized benchmark for corporate sustainability, assessing companies with rigorous evaluation covering Environmental, Social and Governance and industry specific questionnaires, assessing an average of 23 sustainability topic through 150 questions/indicators, evaluating around 13,000 companies worldwide every year.
"JB Pharma’s score reflects its continuous efforts to integrate sustainable practices into its core business operations. Over the past year, JB Pharma has implemented several impactful sustainability initiatives, including renewable energy adoption, rainwater harvesting project, waste reduction programs, increased governance, community development projects etc. These efforts have not only contributed to a positive environmental and social footprint but have also strengthened the Company’s position as a leader in sustainable growth," it added.
"As JB Pharma continues its journey towards a more sustainable future, it remains committed to upholding the highest standards of corporate governance and responsible business practices, ensuring long-term value creation for all stakeholders," it further added.
Read also: Q2 results: JB Chemicals & Pharma reports 36 percent rise in profit after tax at Rs 151 crore
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751